2023 Q2 Form 10-K Financial Statement

#000154812323000072 Filed on April 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $37.51K $30.26K $151.2K
YoY Change 4.14% -44.56% -28.11%
Cost Of Revenue $9.090K $5.530K $36.26K
YoY Change -24.38% 197.31% 15.48%
Gross Profit $28.42K $24.73K $114.9K
YoY Change 18.42% -53.09% -35.76%
Gross Profit Margin 75.77% 81.73% 76.01%
Selling, General & Admin $150.8K $149.4K $620.9K
YoY Change 3.76% -28.45% -1.31%
% of Gross Profit 530.76% 603.92% 540.4%
Research & Development $58.26K $51.35K $223.2K
YoY Change 3.81% -17.07% -15.12%
% of Gross Profit 204.99% 207.64% 194.28%
Depreciation & Amortization $0.00 $19.01K $0.00
YoY Change -100.0%
% of Gross Profit 0.0% 76.87% 0.0%
Operating Expenses $218.2K $200.7K $880.4K
YoY Change 2.19% -25.85% -4.67%
Operating Profit -$180.7K -$176.0K -$729.3K
YoY Change 1.79% -19.25% 2.24%
Interest Expense $30.02K -$21.24K $76.78K
YoY Change 77.38% -12.92% -20.83%
% of Operating Profit
Other Income/Expense, Net -$29.42K $300.00 -$75.58K
YoY Change 76.98% 200.0% -395.57%
Pretax Income -$210.1K -$150.7K -$804.8K
YoY Change 8.23% -37.47% 17.03%
Income Tax
% Of Pretax Income
Net Earnings -$210.1K -$150.7K -$804.8K
YoY Change 8.23% -37.47% 17.03%
Net Earnings / Revenue -560.17% -498.05% -532.45%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 125.6M shares 125.6M shares 123.3M shares
Diluted Shares Outstanding 125.6M shares 123.3M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $3.650K $8.950K $8.950K
YoY Change 13.35% 1654.9% 1654.9%
Inventory
Prepaid Expenses
Receivables $14.55K $20.14K $20.14K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.20K $29.08K $29.08K
YoY Change 47.46% 195.8% 195.83%
LONG-TERM ASSETS
Property, Plant & Equipment $254.5K
YoY Change
Goodwill $4.897M $4.897M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.62K $13.62K $13.62K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $5.136M $5.165M $5.165M
YoY Change 4.6% 5.18% 5.18%
TOTAL ASSETS
Total Short-Term Assets $18.20K $29.08K $29.08K
Total Long-Term Assets $5.136M $5.165M $5.165M
Total Assets $5.155M $5.194M $5.194M
YoY Change 4.71% 5.56% 5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $312.6K $310.0K $310.0K
YoY Change 12.03% 36.89% 25.53%
Accrued Expenses $2.589M $2.417M $2.474M
YoY Change 14.28% 9.66% 12.28%
Deferred Revenue
YoY Change
Short-Term Debt $427.2K $406.0K $406.0K
YoY Change 1.86% -44.27% -44.27%
Long-Term Debt Due $976.4K $766.4K $766.4K
YoY Change 85.98% 68.44% 68.44%
Total Short-Term Liabilities $4.363M $3.957M $3.957M
YoY Change 25.29% 8.87% 8.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $171.2K $198.1K $198.1K
YoY Change
Total Long-Term Liabilities $171.2K $198.1K $198.1K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.363M $3.957M $3.957M
Total Long-Term Liabilities $171.2K $198.1K $198.1K
Total Liabilities $4.534M $4.155M $4.155M
YoY Change 30.2% 14.32% 14.32%
SHAREHOLDERS EQUITY
Retained Earnings -$31.31M -$30.89M
YoY Change 2.53% 2.68%
Common Stock $125.6K $125.6K
YoY Change 0.0% 9.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $620.5K $1.039M $1.039M
YoY Change
Total Liabilities & Shareholders Equity $5.155M $5.194M $5.194M
YoY Change 4.71% 5.56% 5.56%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$210.1K -$150.7K -$804.8K
YoY Change 8.23% -37.47% 17.03%
Depreciation, Depletion And Amortization $0.00 $19.01K $0.00
YoY Change -100.0%
Cash From Operating Activities -$87.04K $25.90K -$319.3K
YoY Change 3.24% -134.16% -27.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 87.04K -25.90K $318.9K
YoY Change 3.24% -133.98% -27.5%
NET CHANGE
Cash From Operating Activities -87.04K 25.90K -$319.3K
Cash From Investing Activities
Cash From Financing Activities 87.04K -25.90K $318.9K
Net Change In Cash 0.000 0.00000000005821 -$398.00
YoY Change -100.0% -199.0%
FREE CASH FLOW
Cash From Operating Activities -$87.04K $25.90K -$319.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2021Q4 us-gaap Assets
Assets
4920373 usd
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
7506 usd
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
0-24368
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0620425
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5718 W Dannon Way
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
West Jordan
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84081
CY2022 dei City Area Code
CityAreaCode
801
CY2022 dei Local Phone Number
LocalPhoneNumber
568-5111
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
3484541 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
125557174 shares
CY2022 dei Auditor Firm
AuditorFirmId
5525
CY2022 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
402 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
103777 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
105790 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20135 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8918 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8948 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
512 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
29083 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
9832 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
13624 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
13624 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
597174 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
597174 usd
CY2022Q4 flxt Patents And Proprietary Technology Net Of Accumulatedamortization
PatentsAndProprietaryTechnologyNetOfAccumulatedamortization
974045 usd
CY2021Q4 flxt Patents And Proprietary Technology Net Of Accumulatedamortization
PatentsAndProprietaryTechnologyNetOfAccumulatedamortization
974045 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
254519 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4896917 usd
CY2021Q4 us-gaap Goodwill
Goodwill
4896917 usd
CY2022Q4 us-gaap Assets
Assets
5194143 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
265267 usd
CY2021Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
226447 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
44713 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
20481 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2416589 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2203727 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
57679 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
766391 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
455000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
180000 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
510000 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
218513 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
218513 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3956658 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3634168 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
198064 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4154722 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3634168 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
125557174 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125557174 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114396242 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114396242 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
125557 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
114396 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31801069 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31254182 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30887205 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30082373 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1039421 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1286205 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5194143 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4920373 usd
CY2022 us-gaap Revenues
Revenues
151156 usd
CY2021 us-gaap Revenues
Revenues
210249 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
36258 usd
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
31400 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
620921 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
629139 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
223227 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
262984 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
880406 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
923523 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-729250 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-713274 usd
CY2022 us-gaap Interest Expense
InterestExpense
76782 usd
CY2021 us-gaap Interest Expense
InterestExpense
96983 usd
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
3 usd
CY2022 us-gaap Other Income
OtherIncome
1200 usd
CY2021 us-gaap Other Income
OtherIncome
100 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
119000 usd
CY2021 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
3452 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-75582 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25572 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-804832 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-687702 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123294410 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113591707 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1973907 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-687702 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1286205 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
558048 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-804832 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1039421 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-804832 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-687702 usd
CY2021 us-gaap Depreciation
Depreciation
1451 usd
CY2021 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
119000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
19011 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11217 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
745 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15093 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-548 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
38820 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6628 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
24232 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
15281 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-11130 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
440910 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
357347 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-319295 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-439448 usd
CY2022 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
7506 usd
CY2021 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-19650 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
10000 usd
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
20000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
321391 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
479500 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
318897 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
439850 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-402 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
402 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
402 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
402 usd
CY2021 flxt Common Stock Issued For Subscription Payable
CommonStockIssuedForSubscriptionPayable
385929 usd
CY2022 flxt Initiation Of Operating Lease
InitiationOfOperatingLease
273530 usd
CY2022 flxt Conversion Of Note Payable And Accrued Interest To Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestToCommonStockToBeIssued
558048 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt/10.65pt Times New Roman, Times, Serif; margin: 0"><b><i>Use of Estimates – </i></b>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates.</p><p style="font: 10pt/10.65pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q4 us-gaap Percentage Of Interest Bearing Domestic Deposits To Deposits
PercentageOfInterestBearingDomesticDepositsToDeposits
0.50 pure
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
103777 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
105790 usd
CY2022Q4 flxt Sale Of Deposit
SaleOfDeposit
0.50 pure
CY2022 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
804832 usd
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
687702 usd
CY2022Q4 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
30887205 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
6500000 usd
CY2022Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
447093 usd
CY2022Q4 flxt Deferred Tax Assets Tax Deferred Expense Origination And Amortization Of Interest On Convertible Notes
DeferredTaxAssetsTaxDeferredExpenseOriginationAndAmortizationOfInterestOnConvertibleNotes
932622 usd
CY2021Q4 flxt Deferred Tax Assets Tax Deferred Expense Origination And Amortization Of Interest On Convertible Notes
DeferredTaxAssetsTaxDeferredExpenseOriginationAndAmortizationOfInterestOnConvertibleNotes
932622 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
158389 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
158389 usd
CY2022Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
107270 usd
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14862493 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16343281 shares
CY2022 flxt Options For Common Stock
OptionsForCommonStock
1900000 shares
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Concentrations and Credit Risk - </i></b>The Company has a few major customers who represents a significant portion of revenue, accounts receivable and notes receivable. During the year ended December 31, 2022, three customers represented 55% of sales and three customers represented 98% of accounts receivable. A customer who is utilizing our technology for commercialization in shoes represented 80% of accounts receivable at December 31, 2022. The Company has a strong relationship with these customers and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.  During 2022, five customers constituted 88% of the sales.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022 flxt Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.88 pure
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
597174 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
597174 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
597174 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
597174 usd
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
974045 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
974045 usd
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
974045 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
974045 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9222589 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8372737 usd
CY2021Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
107270 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
653545 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
653545 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11074415 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10224563 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11074415 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10224563 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24961758 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24111906 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-209256 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-144417 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
209256 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
144417 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions Employee Stock Ownership Plan Dividends
EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends
0.50 pure
CY2022 flxt Expensing Percentage
ExpensingPercentage
1 pure
CY2023Q1 flxt Expensing Percentage
ExpensingPercentage
0.20 pure
CY2022Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
11160932 shares
CY2022Q4 us-gaap Other Loans Payable
OtherLoansPayable
59500 usd
CY2017Q3 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
54513 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
104000 usd
CY2022Q4 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.08 pure
CY2022 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
12 usd
CY2022Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.06
CY2022 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-03-31
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Other Assets
OtherAssets
usd
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
11160932 shares
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
455000 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
103046 usd
CY2021Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
14682778 shares
CY2015Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
225000 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3096000 shares
CY2019Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.15
CY2019Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
2.07
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2451971 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1900000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1900000 shares
CY2021Q4 flxt Share Outstanding
ShareOutstanding
1900000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2021Q4 flxt Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y7M24D
CY2022Q4 flxt Share Outstanding
ShareOutstanding
1900000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2022Q4 flxt Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Terms
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y7M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1900000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.05
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y7M24D
CY2022Q4 us-gaap Area Of Land
AreaOfLand
8029 sqm
CY2022Q4 flxt Operating Lease Monthly Payment Due In Current Year
OperatingLeaseMonthlyPaymentDueInCurrentYear
6787 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
80684 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
83108 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
85604 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
58118 usd
CY2022Q4 flxt Lessee Operating Lease Liability Payments Due Total Payments
LesseeOperatingLeaseLiabilityPaymentsDueTotalPayments
307513 usd
CY2022 flxt Imputed Interest
ImputedInterest
-51771 usd
CY2022Q4 flxt Lease Liability As Of Period End
LeaseLiabilityAsOfPeriodEnd
255743 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
57679 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
198064 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
54257 usd
CY2022 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
114514 usd
CY2022 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
104000 usd
CY2022Q4 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.08 pure
CY2022 us-gaap Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Other Default Rate
HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherDefaultRate
0.12 pure
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
150000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
8000 usd
CY2022 dei Auditor Name
AuditorName
Fruci
CY2021Q4 us-gaap Other Assets
OtherAssets
usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2021Q4 us-gaap Bank Overdrafts
BankOverdrafts
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113591707 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123294410 shares
CY2021 flxt Common Stock Issued In Full Settlement Of Stock Conversion
CommonStockIssuedInFullSettlementOfStockConversion
usd
CY2022 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2021 flxt Initiation Of Operating Lease
InitiationOfOperatingLease
usd
CY2021 flxt Conversion Of Note Payable And Accrued Interest To Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestToCommonStockToBeIssued
usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
usd
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 flxt Income Tax Reconciliation Options Issued For Services
IncomeTaxReconciliationOptionsIssuedForServices
usd
CY2021 flxt Income Tax Reconciliation Options Issued For Services
IncomeTaxReconciliationOptionsIssuedForServices
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022 flxt Share Based Compensation Arrangements Share By Payment Award Option Weighted Average Remaining Contractual Life Years Granted
ShareBasedCompensationArrangementsShareByPaymentAwardOptionWeightedAverageRemainingContractualLifeYearsGranted
CY2022 flxt Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022 flxt Share Based Compensatin Arranged By Share Based Payments Option Weighted Average Remaining Contractual Life Years Expired
ShareBasedCompensatinArrangedByShareBasedPaymentsOptionWeightedAverageRemainingContractualLifeYearsExpired
CY2022 flxt Share Based Compensation Arrangement By Share Based Payment Award Options Expired Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredIntrinsicValue
usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022 flxt Weighted Average Remaining Contractual Life Years Forfeited
WeightedAverageRemainingContractualLifeYearsForfeited
CY2022 flxt Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000925660
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Security12b Title
Security12bTitle
None

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001548123-23-000072-index-headers.html Edgar Link pending
0001548123-23-000072-index.html Edgar Link pending
0001548123-23-000072.txt Edgar Link pending
0001548123-23-000072-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
flxt-20221231.htm Edgar Link pending
flxt-20221231.xsd Edgar Link pending
image_001.gif Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
flxt-20221231_def.xml Edgar Link unprocessable
flxt-20221231_cal.xml Edgar Link unprocessable
flxt-20221231_lab.xml Edgar Link unprocessable
flxt-20221231_pre.xml Edgar Link unprocessable
flxt-20221231_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending